| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |